Balchem Co. (NASDAQ:BCPC) Shares Sold by Wendell David Associates Inc.

Wendell David Associates Inc. decreased its stake in Balchem Co. (NASDAQ:BCPC) by 5.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,577 shares of the basic materials company’s stock after selling 1,200 shares during the period. Wendell David Associates Inc. owned approximately 0.06% of Balchem worth $3,191,000 as of its most recent SEC filing.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Westside Investment Management Inc. purchased a new stake in shares of Balchem in the 3rd quarter worth about $27,000. nVerses Capital LLC acquired a new position in Balchem during the third quarter worth about $35,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Balchem in the third quarter valued at about $35,000. GAMMA Investing LLC increased its stake in shares of Balchem by 73.4% during the 3rd quarter. GAMMA Investing LLC now owns 841 shares of the basic materials company’s stock worth $148,000 after purchasing an additional 356 shares in the last quarter. Finally, Blue Trust Inc. raised its position in shares of Balchem by 642.5% during the 3rd quarter. Blue Trust Inc. now owns 839 shares of the basic materials company’s stock worth $148,000 after purchasing an additional 726 shares during the last quarter. Hedge funds and other institutional investors own 87.91% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on BCPC shares. HC Wainwright lifted their price target on shares of Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, November 4th. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th.

Balchem Trading Down 0.6 %

BCPC opened at $162.10 on Thursday. Balchem Co. has a 52-week low of $137.69 and a 52-week high of $186.03. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. The firm has a market capitalization of $5.27 billion, a P/E ratio of 43.58, a P/E/G ratio of 4.39 and a beta of 0.69. The firm’s 50 day moving average is $169.56 and its 200-day moving average is $170.89.

Balchem Increases Dividend

The business also recently declared an annual dividend, which was paid on Friday, January 17th. Investors of record on Thursday, December 26th were issued a $0.87 dividend. The ex-dividend date of this dividend was Thursday, December 26th. This is a boost from Balchem’s previous annual dividend of $0.79. This represents a yield of 0.4%. Balchem’s dividend payout ratio is currently 23.39%.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.